Table 1.
Multiple regression analysis of overall survival factors by multivariable analysis.
| Analyze | Univariate | Multivariate | ||
|---|---|---|---|---|
| Result | HR (95% CI for HR) | p-Value | HR (95% CI for HR) | p-Value |
| GE score OS + prediction | 0.31 (0.17–0.56) | 0.000095 | 0.39 (0.21–0.7) | 0.002 |
| CA 19–9 (U/mL) | 1 (1–1) | 0.28 | ||
| Albumin (g/L) | 0.97 (0.94–1) | 0.16 | ||
| QLQ-C30 | 1 (1–1) | 0.0027 | 1.02 (1.0–1.04) | 0.015 |
| Body mass index | 0.98 (0.92–1) | 0.5 | ||
| ECOG PS | 1.8 (0.96–3.2) | 0.067 | ||
| Monocyte count (per µL) | 2 (0.9–4.6) | 0.09 | ||
| Tumor localization | ||||
| Head | 0.86 (0.51–1.5) | 0.59 | ||
| Body | 1.1 (0.62–1.9) | 0.81 | ||
| Tail | 1.5 (0.85–2.7) | 0.16 | ||
| Clinical stage | 0.34 (0.17–0.68) | 0.0024 | 0.41 (0.2–0.83) | 0.014 |
Abbreviations: QLQ-C30; European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 item global health status. GE; gene expression. CA19–9; carbohydrate antigen 19–9. ECOG PS; Eastern Cooperative Oncology Group Performance Status.